Breakthrough in Lung Cancer Treatment: Positive Phase 3 OPTITROP-Lung04 Trial Results for Sacituzumab Tirumotecan Unveiled
A New Horizon in Lung Cancer Treatment: FDA Grants Breakthrough Status to Lilly-Merck Combination Therapy